[PPAR-ligands: a clinically important regulatory system with multiple options in the treatment of diabetes mellitus, inflammatory bowel disease and in the chemoprevention of colon cancer?]

[Article in German]

Affiliations

Comment

[Article in German]

H Allgayer et al. Z Gastroenterol. 2003 Oct.

. 2003 Oct;41(10):1035-8.

doi: 10.1055/s-2003-42921.

No abstract available

Comment on

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T, Kojima K, Yoshiura K, Hiraishi H, Terano A. Shimada T, et al. Gut. 2002 May;50(5):658-64. doi: 10.1136/gut.50.5.658. Gut. 2002. PMID: 11950812 Free PMC article.
Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.
Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H, Nakagama H. Osawa E, et al. Gastroenterology. 2003 Feb;124(2):361-7. doi: 10.1053/gast.2003.50067. Gastroenterology. 2003. PMID: 12557142
A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model.
Katayama K, Wada K, Nakajima A, Mizuguchi H, Hayakawa T, Nakagawa S, Kadowaki T, Nagai R, Kamisaki Y, Blumberg RS, Mayumi T. Katayama K, et al. Gastroenterology. 2003 May;124(5):1315-24. doi: 10.1016/s0016-5085(03)00262-2. Gastroenterology. 2003. PMID: 12730872